ArticleFrontiers in pharmacology2021

High Dose Lopinavir/Ritonavir Does Not Lead to Sufficient Plasma Levels to Inhibit SARS-CoV-2 in Hospitalized Patients With COVID-19.

Mario Karolyi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.